We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Drug Cos. Try To Keep Cephalon Case Info Under Wraps

Law360 (January 19, 2011, 1:06 PM EST) -- A slew of drug companies are seeking to intervene in the Federal Trade Commission’s antitrust suit alleging Cephalon Inc. paid off generics competitors in a reverse payment agreement over the patent for narcolepsy drug Provigil.

In a motion filed Tuesday in the U.S. District Court for the Eastern District of Pennsylvania, more than 40 drugs companies — including GlaxoSmithKline PLC, Johnson & Johnson and Pfizer Inc. — asked Judge Mitchell S. Goldberg to bar the disclosure of confidential information about separate lawsuits and settlements.

The companies...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.